KINS trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes KINS achieves its forward estimates and maintains a stable P/E multiple of 7.0x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Kingstone Companies, Inc. (KINS) has a Wall Street consensus price target of N/A, based on estimates from 4 covering analysts. The company has a market capitalization of $269M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, KINS trades at a trailing P/E of 6.4x and forward P/E of 7.0x. The forward PEG ratio of 0.07 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +10.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $18.67, with bear and bull scenarios of $11.76 and $24.60 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HRTGHeritage Insurance Holdings, Inc. | $1.0B | $33.07 | $36.50 | +10.4% | Buy | 6.2x | 9 |
 HIHOHighway Holdings Limited | $4M | $0.94 | — | — | — | — | — |
 ACICAmerican Coastal Insurance Corporation | $442M | $9.11 | $13.00 | +42.7% | Hold | 9.3x | 5 |
 HCIHCI Group, Inc. | $2.2B | $176.12 | $225.00 | +27.8% | Buy | 9.2x | 14 |
 PLMRPalomar Holdings, Inc. | $3.4B | $127.21 | $158.50 | +24.6% | Buy | 12.6x | 11 |
 NODKNI Holdings, Inc. | $302M | $14.76 | — | — | — | — | — |
 KPTIKaryopharm Therapeutics Inc. | $40M | $1.75 | $14.17 | +709.7% | Buy | — | 20 |
 SIGISelective Insurance Group, Inc. | $5.1B | $86.33 | $98.75 | +14.4% | Hold | 10.6x | 16 |
 ERIEErie Indemnity Company | $10.4B | $225.77 | — | — | — | 17.8x | — |
 RNRRenaissanceRe Holdings Ltd. | $13.7B | $328.80 | $332.29 | +1.1% | Hold | 7.6x | 28 |
Quick answers to the most common questions about buying KINS stock.
The consensus price target for KINS is $N/A, close to the current price of $18.57 (N/A% implied move). Based on 4 analyst estimates, the stock appears fairly valued near current levels.
KINS has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 7.0075x, KINS trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for KINS, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $25 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
KINS is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month KINS stock forecast based on 4 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $19, with bear/bull scenarios of $12/$25.
Our quantitative valuation model calculates KINS's fair value at $19 (base case), with a bear case of $12 and bull case of $25. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
KINS trades at a forward P/E ratio of 7.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 6.4x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
KINS appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
KINS analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $12-$25 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.